DrNB Neonatology: Admissions, Medical Colleges, Eligibility Criteria, Fee Details
Turner Syndrome News, Research And Latest Updates
Keep abreast with the latest news related to Turner Syndrome there are 132 news items on Turner Syndrome that covers updates, breakthroughs and in-depth reports.We provide you with a free downloadable secure widget for your website to carry news related to Turner Syndrome.Foundation Opens To Support Idahoans Struggling With Turner Syndrome
In Idaho, there are 481 women and girls with Turner syndrome, according to the Turner Syndrome Foundation.
BOISE, Idaho — An Idaho woman founded the Idaho Turner Foundation last summer when she discovered her daughter had the condition and there weren't many resources for them to turn to in the Gem State.
Around 1 in every 2,500 female births is affected by Turner syndrome. In Idaho, 481 women and girls have this genetic disorder, according to the Turner Syndrome Foundation. Previously, resources were scarce for those affected by Turner syndrome in Idaho. However, the Idaho Turner Foundation, created by Alissa Sprute, now offers valuable support and aid.
Sprute had never heard of Turner syndrome until her daughter was diagnosed in January of this year.
"I was on Google trying to figure out, you know, what is this... And it was very ... I felt very defeated," she said
Turner syndrome is a condition that affects only females. It happens when one of the X chromosomes is missing or partially missing. As a result, they may face various developmental and medical challenges, such as insufficient growth, heart defects, and infertility problems.
Sprute said she felt isolated when she figured out her daughter was diagnosed with the condition.
"I didn't know what the next steps were, what things would look like for her," she said.
One day, Sprute was on her way to work, sat in her car, and decided things needed to change. She then started the Idaho Turner Syndrome Foundation, which put her in touch with Jacquelyn Wooldridge.
"There are many women and girls who feel that they are the only ones," Wooldridge said.
Wooldridge was diagnosed with Turner syndrome when she was five years old.
"My mom took me to my pediatrician and had my younger sister, who was two years old at the time, stand next to me and said, 'Tell me there's nothing wrong with her.,'" she said. "I was five years old and the size of a two-year-old."
KTVB last reported about Wooldridge last year in February when Governor Brad Little proclaimed February as Turner Syndrom Awareness Month.
"We like to call ourselves, were the 2%," Wooldridge said. "Because one to 3% of the birth of the pregnancies where the child has Turner syndrome come to fruition. So we're the lucky 2%."
People with Turner syndrome have chosen the butterfly to symbolize themselves.
"It is a feminine symbol," she said. "They are unique and very special creatures."
The organization's goals are to help connect families who have daughters with the condition and help provide support for families in need.
"We also want to be able to provide help financially for out-of-state medical since there are no specialists in Idaho," she said. "Also, hopefully, down the road, be able to do scholarships for adoption funds because it's harder for them to have kids."
The closest clinics specializing in Turner syndrome and other growth disorders are in Seattle, Colorado or Las Vegas.
For more resources about and information about the condition, visit their website here.
See the latest news from around the Treasure Valley and the Gem State in our YouTube playlist:
HERE ARE MORE WAYS TO GET NEWS FROM KTVB:
Download the KTVB News Mobile App
Apple iOS: Click here to download
Google Play: Click here to download
Watch news reports for FREE on YouTube: KTVB YouTube channel
Stream Live for FREE on ROKU: Add the channel from the ROKU store or by searching 'KTVB'.
Stream Live for FREE on FIRE TV: Search 'KTVB' and click 'Get' to download.
Turner Syndrome Market Is Projected To Grow At A CAGR Of 7.28% From 2023-2033
Market Overview:
The turner syndrome market is expected to exhibit a CAGR of 7.28% during 2023-2033.
The report offers a comprehensive analysis of the turner syndrome market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the markets performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the turner syndrome market.
Request for a Sample Copy of this Report:https://www.Imarcgroup.Com/turner-syndrome-market/requestsample
The Turner syndrome market is undergoing significant expansion, driven by various market drivers reshaping the landscape of diagnosis, treatment, and patient care for this rare genetic condition. Turner syndrome, characterized by the partial or complete absence of one X chromosome in females, poses unique medical challenges. Greater demand for diagnostic and therapeutic alternatives is the result of growing awareness among patients, healthcare professionals, and the general public. Furthermore, ongoing research on the genetic basis of Turner syndrome has provided valuable insights into its underlying causes. This knowledge has paved the way for developing targeted therapies and personalized treatment approaches. Additionally, regulatory authorities have recognized Turner syndrome as an orphan disease, incentivizing pharmaceutical companies to invest in drug development. Hormone replacement therapy (HRT) is a cornerstone of Turner syndrome treatment.
Advancements in HRT have improved patients quality of life, addressing growth and developmental concerns. The healthcare industry increasingly adopts a patient-centered approach, involving patients in treatment decisions and research efforts and ensuring that therapies address the specific needs and challenges individuals with Turner syndrome face. Regulatory agencies have introduced expedited pathways for rare disease treatments, reducing approval timelines and facilitating quicker access to innovative therapies for Turner syndrome patients. Increased research funding for Turner syndrome has accelerated the development of novel treatments, including growth-promoting therapies and potential interventions addressing associated health issues. Collaboration between pharmaceutical companies, research institutions, and healthcare providers has led to more extensive clinical trials and data sharing, accelerating Turner syndrome research, which is expected to propel the market in the coming years.
Countries Covered:
? United States ? Germany ? France ? United Kingdom ? Italy ? Spain ? Japan
Analysis Covered Across Each Country:
? Historical, current, and future epidemiology scenario ? Historical, current, and future performance of the turner syndrome market ? Historical, current, and future performance of various therapeutic categories in the market ? Sales of various drugs across the turner syndrome market ? Reimbursement scenario in the market ? In-market and pipeline drugs
This report also provides a detailed analysis of the current turner syndrome marketed drugs and late-stage pipeline drugs.
In-Market Drugs:
? Drug Overview ? Mechanism of Action ? Regulatory Status ? Clinical Trial Results ? Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
? Drug overview ? Mechanism of action ? Regulatory status ? Clinical trial results ? Drug uptake and market performance
Competitive Landscape :
The competitive landscape of the turner syndrome market has been studied in the report with the detailed profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.Imarcgroup.Com/request?Type=report&id=7733&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.Com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.Imarcgroup.Com/
The post Turner Syndrome Market is Projected to Grow at a CAGR of 7.28% from 2023-2033 appeared first on Super Market Research.
COMTEX_441407602/2607/2023-10-04T04:39:51
© 2023 Benzinga.Com. Benzinga does not provide investment advice. All rights reserved.
Comments
Post a Comment